GlobeNewswire
INmune Bio Announces FDA Alignment on Integrated Phase 2b/3 Registration Pathway for XPro1595 in Early Alzheimer’s Disease
📈
AI Sentiment
Highly Positive
9/10
- Home
- INMB
INMB
INmune Bio Inc.
as of 02-13-2026 3:35pm EST
$1.44
$0.03
-2.04%
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | BOCA RATON |
| Market Cap: | 40.1M | IPO Year: | 2019 |
| Target Price: | $4.30 | AVG Volume (30 days): | 332.6K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.38 - $11.64 | Next Earning Date: | 03-26-2026 |
| Revenue: | $50,000 | Revenue Growth: | 19.05% |
| Revenue Growth (this year): | 264.29% | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -31550000.0 | FCF Growth: | N/A |
AI-Powered INMB Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 72.78%
72.78%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest INmune Bio Inc. News
INMB Breaking Stock News: Dive into INMB Ticker-Specific Updates for Smart Investing
TipRanks
INmune Bio submits pre-submission package for CORDStrom with MHRA
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB
📈
AI Sentiment
Highly Positive
9/10
Compare INMB vs Leading Stocks
See how INMB stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "INMB INmune Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.